New CurQD Research Makes Waves at USA's Largest GI Conference | Evinature
Product StagePartners
CurQD Protocol by Evinature Highlighted at Crohn’s & Colitis Congress 2025
Tal’s Journey: Overcoming 16 Years of IBD - evinature
Product Stage
Evinature Co-Founder Dr. Prof. Shomron Ben Horin, MD Presents Groundbreaking CurQD® Research at GEDII Conference in Portugal
Lucy’s Journey to Remission: How CurQD Transformed Her Life - evinature
Evinature Co-Founder Nir Salomon, ChB, Shares Insights in Live Interview with Leading IBD Advocate
Product StageCustomers
Evinature Takes Center Stage at AIBD Conference
CurQD by Evinature Found to Ease Life-Altering IBD Symptom
Customers
Evinature's CurQD Successful in Pediatric Trial
The efficacy of CurQD in children with active ulcerative colitis: a multicenter retrospective cohort study
6 Companies Making Waves in Modern Innovation
These are the 5 Next-Gen Startups Disrupting Their Industries - The World Financial Review
6 Companies That Are Redefining Their Markets
CustomersPartnersInvestmentAcquisitionPublic TradingManagement ChangesLayoffsExpand
Evinature listed top among most-watched Health Tech companies in Startup Nation's H1 2024 Israeli Tech Report
N/A
Meet The Research Team That Broke The Therapeutic Ceiling In IBD - Healthcare Business Today
CustomersPartners
Breaking Boundaries in IBD: Evinature's CurQD® Trial Spotlighted at the CCF’s IBD Innovate Conference 2024 | BioPharma Dive
PartnersCustomers
Meet the Frontmen of Evinature, the Startup That’s Revolutionizing IBD Care | The Ritz Herald
CustomersExpand
Healthcare startup Evinature is now integrated across 35 US medical centres to further streamline IBD treatment accessibility - Digital Journal
CustomersPartners
Evinature: Pioneering Integrative Therapies for IBD with the CurQD® Protocol - Women's Journal
CustomersExpand
Harvard Medical Professor Ashwin Ananthakrishnan Commends Evinature’s CurQD® Trial in CGH Editorial - The European Business Review
CustomersPartners